Data on Investigational Hepatitis C Treatment Reported (Hepatitis C Treatment)

Data on Investigational Hepatitis C Treatment Reported
DATA ON INVESTIGATIONAL HEPATITIS C TREATMENT REPORTED -- Fifteen Abstracts on PEGASYS to be Presented at Liver Disease Meeting -- The American Association for the Study of Liver Disease

Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON

Hepatitis
Phase I Hepatitis C Treatment Trial A new Phase I clinical trial to test a potential treatment for Hepatitis C is enrolling patients. Unlike most Phase I trials, which seek healthy volunteers, this